Home › Funds › FCPM III SERVICES B.V. › DYN
FCPM III SERVICES B.V. position in DYN
DYNE THERAPEUTICS INC · Health Care
FCPM III SERVICES B.V. reported holding 3,848,256 shares of DYN (DYNE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$85.5M, representing 11.39% of its reported portfolio and ranking #3 among its reported holdings. FCPM III SERVICES B.V. has disclosed DYN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How FCPM III SERVICES B.V.'s DYN position evolved
FCPM III SERVICES B.V. first disclosed a stake in DYN in Q4 2023 at 6,131,079 shares (US$81.5M). The position peaked in Q2 2024 at 7,845,364 shares, worth US$276.9M. Across 11 filings, FCPM III SERVICES B.V. increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 3,848,256 shares valued at US$85.5M — a reduction of -796,130 shares quarter over quarter.. Notable position changes include a 28% increase in Q1 2024 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 6.13M | $81.54M | New |
| Q1 2024 | 7.85M | $222.73M | Add |
| Q2 2024 | 7.85M | $276.86M | Hold |
| Q3 2024 | 5.95M | $213.87M | Reduce |
| Q4 2024 | 5.46M | $128.70M | Reduce |
| Q1 2025 | 5.46M | $57.14M | Hold |
| Q2 2025 | 5.46M | $52.01M | Hold |
| Q3 2025 | 5.46M | $69.11M | Hold |
| Q4 2025 | 5.46M | $106.85M | Hold |
| Q1 2026 | 4.64M | $84.20M | Reduce |
| Q2 2026 | 3.85M | $85.47M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About DYN and 13F data
DYN (DYNE THERAPEUTICS INC) is a Health Care company. 41 other funds we track also report a position in DYN — the largest reported positions include Atlas Venture Life Science Advisors, LLC (US$151.0M), TCG Crossover Management, LLC (US$102.5M), Vestal Point Capital, LP (US$75.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding DYN
- Atlas Venture Life Science Advisors, LLC 6.80M sh · $151.03M · Q2 2026
- TCG Crossover Management, LLC 4.62M sh · $102.50M · Q2 2026
- Vestal Point Capital, LP 3.38M sh · $74.96M · Q2 2026
- ORBIMED ADVISORS LLC 3.24M sh · $71.86M · Q2 2026
- Frazier Life Sciences Management, L.P. 3.15M sh · $70.03M · Q2 2026
- ARMISTICE CAPITAL, LLC 3.09M sh · $68.57M · Q2 2026
- PERCEPTIVE ADVISORS LLC 2.69M sh · $59.73M · Q2 2026
- Logos Global Management LP 2.55M sh · $56.64M · Q2 2026
- Venrock Adviser, LLC 2.17M sh · $48.28M · Q2 2026
- Siren, L.L.C. 2.13M sh · $47.29M · Q2 2026
- MPM BioImpact LLC 1.92M sh · $42.69M · Q2 2026
- SAMLYN CAPITAL, LLC 1.75M sh · $38.97M · Q2 2026
More on FCPM III SERVICES B.V.
FAQ
How long has FCPM III SERVICES B.V. held DYN?
FCPM III SERVICES B.V. has disclosed DYN holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is FCPM III SERVICES B.V.'s current position in DYN?
As of Q2 2026, FCPM III SERVICES B.V. holds 3.85M shares of DYN (DYNE THERAPEUTICS INC), valued at $85.47M, representing 11.39% of its reported portfolio and ranking #3.
Has FCPM III SERVICES B.V. been buying or selling DYN?
In the latest 13F filing (Q2 2026), FCPM III SERVICES B.V. reduced its position in DYN. The position peaked in Q2 2024 at 7.85M shares.
Which other funds hold DYN?
Other major institutional holders of DYN include Atlas Venture Life Science Advisors, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.